Real-time enrollment status for this secondary hemophagocytic lymphohistiocytosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT05416307 |
| Recruiting Status | Recruiting |
| Condition | Secondary Hemophagocytic Lymphohistiocytosis |
| Phase | Clinical Trial |
| Target Enrollment | 156 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Electra Therapeutics Inc. |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT05416307 is currently recruiting participants. This clinical trial study for secondary hemophagocytic lymphohistiocytosis is actively seeking new participants at 10 locations across the United States. The study is sponsored by Electra Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05416307 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05416307 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.